Accolade Inc

Aktienanalyse zu Accolade Inc (ACCD)

$7.020

-0.010 (-0.14%)Zum Schluss

Loading chart…
Hoch
7.030
Eröffnung
7.030
Volumengewichteter Durchschnittskurs
7.02
Volumen
4.59M
Marktkap.
511.25M
Tief
7.010
Umsatz
32.19M
EV/EBITDA, TTM
16.63

Accolade, Inc. provides personalized, technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. Its customers are primarily employers that deploy Accolade solutions in order to provide employees and their families with a single place to turn for their health, healthcare, and benefits needs. It also offers medical opinion services to commercial customers and virtual primary care and mental health support. Its platform, True Health Engine, combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. Its offerings include Accolade Expert MD, Accolade Care, Plus and Connect and Accolade One.

www.accolade.com

Bewertungskennzahlen

Das aktuelle erwartete KGV von Accolade Inc (ACCD) beträgt -50.82, verglichen mit dem 5-Jahres-Durchschnitt von -18.90.

Erwartetes KGV

Stark unterbewertet
5J-Durchschnitt P/E
-18.90
Aktuelles P/E
-50.82
Überbewertet
-8.25
Unterbewertet
-29.56

Erwartetes EV/EBITDA

Fair bewertet
5J-Durchschnitt EV/EBITDA
-23.89
Aktuelles EV/EBITDA
16.63
Überbewertet
122.46
Unterbewertet
-170.23

Erwartetes KUV

Fair bewertet
5J-Durchschnitt P/S
1.98
Aktuelles P/S
1.10
Überbewertet
3.30
Unterbewertet
0.66

Event-Zeitleiste

2025-04-22 (ET)

08:30:04

Thirteen option delistings on April 22nd

2025-03-27 (ET)

16:21:57

Accolade announces stockholder approval for Transcarent merger

2025-02-24 (ET)

17:22:32

Accolade and Transcarent announce HSR waiting period expiration for merger

2025-01-13 (ET)

06:08:49

Accolade downgraded to Hold from Buy at Truist

2025-01-08 (ET)

12:15:09

Accolade downgraded to Hold from Buy at Needham

News

ACCD FAQ – beantwortet von Alphio AI

Accolade, Inc. provides personalized, technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. Its customers are primarily employers that deploy Accolade solutions in order to provide employees and their families with a single place to turn for their health, healthcare, and benefits needs. It also offers medical opinion services to commercial customers and virtual primary care and mental health support. Its platform, True Health Engine, combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. Its offerings include Accolade Expert MD, Accolade Care, Plus and Connect and Accolade One. It operates in the Healthcare sector (SERVICES-BUSINESS SERVICES, NEC industry).

Community

Mehr ↗

Noch keine Beiträge

Registriere dich oder melde dich an, um mitzudiskutieren

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Jetzt handeln